retinoblastoma diagnostics

BMS Event: Retinoblastoma Diagnostics

kinderkrebsstiftung, dr gregor königDr. Gregor König, Kinderkrebsstiftung and Melanie Leddermann, MPIKG BMS ; Photo credits: Dr. Dana Kikic

The Glycobiology Group of the MPI-KG BMS (Prof. Peter H. Seeberger, Dr. Chakkumkal Anish, Mr. Geißner), Kinderkrebsstiftung (Dr. Gregor König), sphingotec GmbH (Dr. Andreas Bergmann) and University Klinikum Essen (Dr. Petra Temming and Prof. Johannes Schulte) joined their expertise to identify novel glycan-based tumor markers or tumour associated carbohydrate antigens (TACA) for potential diagnosis and prognosis of the retinoblastoma disease. ...